These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33451781)

  • 1. Potential for improving routine immunisation waste management using measles vaccination campaign 2017 in Kebbi State, Nigeria.
    Oteri J; Bawa S; Christopher E; Nsubuga P; Dieng B; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C60-C65. PubMed ID: 33451781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
    Momoh J; Oteri AJ; Mogekwu F; Onwu N; Dieng B; Bawa S; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C12-C20. PubMed ID: 33714654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of WhatsApp group messaging in the coordination of measles supplemental immunization activity in Cross Rivers State, Nigeria, 2018.
    Masresha B; Nwankwo O; Bawa S; Igbu T; Oteri J; Tafida H; Braka F
    Pan Afr Med J; 2020; 35(Suppl 1):6. PubMed ID: 32373257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress Towards Measles Elimination in Nigeria: 2012 - 2016.
    Masresha B; Braka F; Onwu NU; Oteri J; Erbeto T; Oladele S; Sumaili K; Aman-Oloniyo A; Katsande R; Tegegn SG; Fall A
    J Immunol Sci; 2018 Aug; Suppl():135-139. PubMed ID: 30957102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Contribution of Supplementary Immunization Activities to Routine Immunization in Kebbi State, Nigeria.
    Omoleke SA; Getachew B; Igoh CS; Yusuf TA; Lukman SA; Loveday N
    J Prim Care Community Health; 2020; 11():2150132720932698. PubMed ID: 32508212
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microplanning verification and 2017/2018 measles vaccination campaign in Nigeria: Lessons learnt.
    Hamisu M; Dieng B; Taiwo L; Jean Baptiste AE; Bawa S; Wagai J; Ibizugbe S; Braka F; Nsubuga P; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C46-C53. PubMed ID: 33892983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria.
    Peter KB; Ademola AS; Oyeku OA
    Afr Health Sci; 2014 Mar; 14(1):131-5. PubMed ID: 26060469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.
    Fields R; Dabbagh A; Jain M; Sagar KS
    Vaccine; 2013 Apr; 31 Suppl 2():B115-21. PubMed ID: 23598472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging on the 2017/2018 measles vaccination campaign to improve health workers knowledge and practice on injection safety: A case study of north-central states, Nigeria.
    Okoronkwo C; Taiwo LA; Asolo JA; Jean Baptiste AE; Wagai J; Nsubuga P; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C54-C59. PubMed ID: 34024661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Terna Richard M; Taiwo L; Jean Baptiste AE; Bawa S; Dieng B; Wiwa O; Lambo K; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C21-C28. PubMed ID: 34247903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
    Oyo-Ita A; Bosch-Capblanch X; Ross A; Oku A; Esu E; Ameh S; Oduwole O; Arikpo D; Meremikwu M
    PLoS One; 2021; 16(4):e0248236. PubMed ID: 33861742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of polio supplementary immunisation activities on routine immunisation and health systems: a systematic review.
    Vassallo A; Dunbar K; Ajuwon B; Lowbridge C; Kirk M; King C; Sheel M
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34776411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand.
    Hayman DTS; Marshall JC; French NP; Carpenter TE; Roberts MG; Kiedrzynski T
    Vaccine; 2017 Sep; 35(37):4913-4922. PubMed ID: 28802754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
    Oyo-Ita AE; Hanlon P; Nwankwo O; Bosch-Capblanch X; Arikpo D; Esu E; Auer C; Meremikwu M
    PLoS One; 2021; 16(9):e0257277. PubMed ID: 34529714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.